Evidence map›Paper›PMID 42827507›Full record

ArticleFrontiers in public health2026

Psychological vulnerability and opioid medication use disorder risk in chronic pain: the mediating role of affective states and gender differences.

Jesús D Lorente, Francisco Molins, Félix Padilla, Diana Serrano-Herrera, Vicente Monsalve Dolz, Ana Mínguez, Jose De Andres, Miguel Ángel Serrano, Lucía Hipólito

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jesús D LorenteUniversity Institute of Biotechnology and Biomedicine (BIOTECMED), University of Valencia, Burjassot, Spain.
Francisco MolinsDepartment of Psychobiology, University of Valencia, Valencia, Spain.
Félix PadillaDepartment of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Burjassot, Spain.
Diana Serrano-HerreraDepartment of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Burjassot, Spain.
Vicente Monsalve DolzDepartment of Anaesthesia, Critical Care and Pain Medicine, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
Ana MínguezDepartment of Anaesthesia, Critical Care and Pain Medicine, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
Jose De AndresDepartment of Anaesthesia, Critical Care and Pain Medicine, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
Miguel Ángel SerranoDepartment of Psychobiology, University of Valencia, Valencia, Spain.
Lucía HipólitoUniversity Institute of Biotechnology and Biomedicine (BIOTECMED), University of Valencia, Burjassot, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chronic pain is a leading cause of disability and a major public health concern, frequently accompanied by anxiety and depressive symptoms that may increase vulnerability to opioid medication misuse (OMUD). While affective mechanisms linking pain intensity to the risk of suffering an opioid use disorder have been documented primarily in Anglo-Saxon populations, evidence from Southern European healthcare contexts remains limited. Replicating these pathways across healthcare systems is essential to inform prevention-oriented pain management strategies. This study examined whether negative affective states mediate the relationship between subjective pain intensity and opioid medication use disorder risk in a Spanish clinical sample and whether these associations differ by gender. Methods: Ninety-seven patients attending a specialized pain unit in Spain completed validated measures of pain intensity (visual analog scale, VAS), anxiety (Beck Anxiety Inventory, BAI), depression (Beck Depression Inventory II fast screen, BDI-FS), anhedonia (Snaith-Hamilton Pleasure Scale, SHAPS), and OMUD risk (current opioid misuse measure, COMM). Correlational, mediation (Sobel test), gender-stratified, and cluster analyses were conducted. Results: Pain intensity was positively associated with anxiety, depression, and OMUD risk. Anxiety and depression significantly mediated the association between pain and OMUD risk, with effects observed in women but not in men. The cluster analysis identified a subgroup characterized by elevated negative affect that showed significantly higher pain intensity and markedly greater OMUD risk. Discussion: These findings replicate affective mediation models in a Spanish healthcare context and underscore the systemic relevance of psychological vulnerability in chronic pain. From a public health perspective, integrating routine psychological screening in pain services may strengthen risk stratification, support safer opioid prescribing, and promote more integrated models of care. Consideration of gender differences may further enhance equity and precision in chronic pain management policies.

Indexed as

AffectAnalgesics, OpioidChronic PainOpioid-Related DisordersAdultAnxietyDepressionFemaleHumansMaleMiddle AgedRisk FactorsSex FactorsSpainAnalgesics, Opioidanhedoniaanxietychronic paindepressionopioids

Identifiers

PMID42827507
PMCPMC13630931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.